Celanese Price Prediction: Iran Pushes Target Toward 81
Citi lifts Celanese's price target to 81 amid rising Iran risk and potential Strait of Hormuz disruption, pointing to...
Timing matters: choose or avoid depending on goals, fees, and flexibility. This guide offers practical criteria to decide for retirement planning.
21,768 articlesCiti lifts Celanese's price target to 81 amid rising Iran risk and potential Strait of Hormuz disruption, pointing to...
A four-name AI momentum basket — NVIDIA, AMD, Palantir and TESLA — drives 2027–2029 price targets as AI demand and EV...
UBS boosts its price target on Xcel Energy to $89 while maintaining a Buy rating, saying the stock could year-end hig...
SpaceX is hovering around its $135 IPO price as investors digest post-debut dynamics. One broker, Raymond James, argu...
UBS cuts Mosaic’s price target to $27, citing squeezed phosphate margins from higher sulfur and input costs, as Wall ...
Markets are sizing Coca-Cola for a two-year path as AI-driven capital shifts reshape sectors. A fresh price predictio...
Meta Platforms is pursuing a bold path toward a $9 trillion market cap by 2031. This article breaks down the feasibil...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Oppenheimer boosts its Palo Alto Networks price target to $275 citing strong demand for the Idira identity security p...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Meme coins grab headlines and wallets alike. This guide dives into Dogecoin and Pepe, breaking down what makes each t...
Palantir Technologies presents a paradox: strong fundamentals on one hand, a volatile stock on the other. This articl...